{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:12:08Z","timestamp":1791213128532,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.atherosclerosis.2011.03.043","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T09:13:12Z","timestamp":1302513192000},"page":"518-524","source":"Crossref","is-referenced-by-count":75,"title":["Activation of Th17\/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome"],"prefix":"10.1016","volume":"217","author":[{"given":"Zhao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0010","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jacc.2005.03.040","article-title":"Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes","volume":"45","author":"Methe","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0015","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","article-title":"In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice","volume":"104","author":"Laurat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in apoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/10799900260100141","article-title":"IFN-\u03b3 deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E\u2212\/\u2212 mice","volume":"22","author":"Whitman","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0035","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0040","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell Type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0055","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0060","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbrc.2010.03.090","article-title":"The role of oxidized low-density lipoprotein in breaking peripheral Th17\/Treg balance in patients with acute coronary syndrome","volume":"394","author":"Li","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0075","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0080","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice","volume":"119","author":"Bending","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0090","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.87.6.1938","article-title":"Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease","volume":"87","author":"Bogaty","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0095","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCULATIONAHA.105.537712","article-title":"Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism","volume":"113","author":"De Palma","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2010.12.007","article-title":"The double-faced metabolic andinflammatory effects of standard drug therapy in patients after percutaneous treatment with drug-eluting stent","volume":"215","author":"WuY","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0110","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.178.1.592","article-title":"An inflammatory pathway of IFN-gamma production in coronary atherosclerosis","volume":"178","author":"Ranjbaran","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2011.03.043_bib0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00262-010-0849-6","article-title":"Th17 cells: positive or negative role in tumor?","volume":"59","author":"Ji","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2008.12.032","article-title":"Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet","volume":"47","author":"Pejnovic","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2004.01.007","article-title":"Increased Th1 activity in patients with coronary artery disease","volume":"26","author":"Fernandes","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2011.03.043_bib0145","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2009-03-209189","article-title":"Do studies in humans better depict Th17 cells?","volume":"114","author":"Annunziato","year":"2009","journal-title":"Blood"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T12:51:26Z","timestamp":1543841486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011003042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0021915011003042"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.03.043","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}